PortfoliosLab logo

Adverum Biotechnologies, Inc. (ADVM)

Equity · Currency in USD · Last updated Mar 29, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Adverum Biotechnologies, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $286 for a total return of roughly -97.14%. All prices are adjusted for splits and dividends.

ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADVM

Adverum Biotechnologies, Inc.


Adverum Biotechnologies, Inc. had a return of 37.93% year-to-date (YTD) and -45.58% in the last 12 months. Over the past 10 years, Adverum Biotechnologies, Inc. had an annualized return of -33.71%, while the S&P 500 had an annualized return of 8.70%, indicating that Adverum Biotechnologies, Inc. did not perform as well as the benchmark.

1 month14.29%0.03%
6 months-13.04%8.65%
1 year-45.58%-12.59%
5 years (annualized)-32.40%8.81%
10 years (annualized)-33.71%8.70%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adverum Biotechnologies, Inc. Sharpe ratio is -0.70. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Dividend History

Adverum Biotechnologies, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Adverum Biotechnologies, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adverum Biotechnologies, Inc. is 99.10%, recorded on Dec 27, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.1%Jan 8, 20152007Dec 27, 2022
-19.26%Aug 1, 20143Aug 5, 20149Aug 18, 201412
-17.74%Sep 30, 20149Oct 10, 201417Nov 4, 201426
-12.89%Sep 15, 20145Sep 19, 20145Sep 26, 201410
-10.31%Nov 5, 201411Nov 19, 20144Nov 25, 201415
-8.51%Dec 23, 20142Dec 24, 20142Dec 29, 20144
-8.47%Jan 6, 20151Jan 6, 20151Jan 7, 20152
-7.31%Aug 21, 20144Aug 26, 201411Sep 11, 201415
-5.55%Nov 28, 20142Dec 1, 20142Dec 3, 20144
-3.38%Dec 31, 20141Dec 31, 20141Jan 2, 20152

Volatility Chart

Current Adverum Biotechnologies, Inc. volatility is 87.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)